|
|
|
National Stock Number:
6505-01-103-6335
Federal Supply Class:
6505
National Item Identification Number:
011036335
Description:
CIMETIDINE TABLETS
|
Manufacturer Information:
| NDC00108-5012-20 | 93544 | GLAXOSMITHKLINE HOLDINGS AMERICAS INC. DIV DBA SMITHKLINE BEECHAM CORPORATION | | NDC00364-2591-01 | 0PTT8 | SCHEIN PHARMACEUTICAL INC | | NDC00781-1447-01 | 0THL4 | SANDOZ INC. | | NDC55953-0181-40 | 0U3G2 | NOVOPHARM USA INC | | NDC00378-0053-01 | 3KJG9 | MYLAN PHARMACEUTICALS INC | | NDC00378-0053-01 | 60895 | MYLAN PHARMACEUTICALS INC | | NDC60951-0630-70 | 1DBS1 | ENDO PHARMACEUTICALS INC | | TAGAMET | 93544 | GLAXOSMITHKLINE HOLDINGS AMERICAS INC. DIV DBA SMITHKLINE BEECHAM CORPORATION | | TAGAMET TABLETS | 93544 | GLAXOSMITHKLINE HOLDINGS AMERICAS INC. DIV DBA SMITHKLINE BEECHAM CORPORATION |
|
Techincal Specification:
| ACTIVE MEDICAMENT MEDICINAL STRENGTH | 200.000 MILLIGRAMS CIMETIDINE ACTIVE INGREDIENT | | ADMINISTRATION | ORAL | | MEDICAL DESIGNATION AND GRADE | UNITED STATES PHARMACOPEIA | | PRIMARY CONTAINER CONTENT QUANTITY | 100.000 TABLETS | | PRIMARY CONTAINER TYPE | BOTTLE | | PART NAME ASSIGNED BY CONTROLLING AGENCY | CIMETIDINE TABLETS 200MG 100S |
|